In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

And per the American Academy of Dermatology Association, sometimes skin changes like rashes, “netting”, and the appearance of lumps can reveal underlying heart issues, too. The British Journal of ...

These lesions, which can appear on 20 per cent to 50 per cent of the body, develop into grey or brown patches which fade with age, becoming lighter than the skin colour, Dr Koh added.

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

RA primarily affects the joints, but it can also cause symptoms in other areas of the body, such as the skin. Learn how RA ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The generalized erythroderma form presents with skin lesions resembling an exfoliative erythroderma (Bolognia et al., 2008). Bullae may develop but are not always present.

The US FDA has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid.

Patient remained without skin lesions for three months, and resumed the use of vaccines without live antigens according to the national vaccination calendar. At nine months old, she received acellular ...

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...